Do we learn the right things from clinical trials?
- First Online:
- Cite this article as:
- Garattini, S. & Bertele’, V. Eur J Clin Pharmacol (2008) 64: 115. doi:10.1007/s00228-007-0411-4
KeywordsAdded value Adverse reactions Clinical end-points Clinical drug trials Comparators Design Conflicts of interest Randomization
© Springer-Verlag 2007